CN106520857A - 一种酶法合成氨曲南的方法 - Google Patents
一种酶法合成氨曲南的方法 Download PDFInfo
- Publication number
- CN106520857A CN106520857A CN201610718795.9A CN201610718795A CN106520857A CN 106520857 A CN106520857 A CN 106520857A CN 201610718795 A CN201610718795 A CN 201610718795A CN 106520857 A CN106520857 A CN 106520857A
- Authority
- CN
- China
- Prior art keywords
- azt
- amino
- aztreonam
- water
- methyls
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 31
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 22
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 22
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 229960003644 aztreonam Drugs 0.000 title claims abstract description 20
- 230000002194 synthesizing effect Effects 0.000 title abstract description 3
- 150000002148 esters Chemical class 0.000 claims abstract description 19
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 5
- 239000007858 starting material Substances 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 21
- 210000004185 liver Anatomy 0.000 claims description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- 108090000371 Esterases Proteins 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 230000003647 oxidation Effects 0.000 claims description 13
- 238000007254 oxidation reaction Methods 0.000 claims description 13
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 claims description 12
- 229960004261 cefotaxime Drugs 0.000 claims description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 238000000967 suction filtration Methods 0.000 claims description 10
- 238000007792 addition Methods 0.000 claims description 9
- 150000001539 azetidines Chemical class 0.000 claims description 8
- 238000005352 clarification Methods 0.000 claims description 8
- 238000010511 deprotection reaction Methods 0.000 claims description 8
- 230000002255 enzymatic effect Effects 0.000 claims description 8
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 235000015277 pork Nutrition 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 239000003125 aqueous solvent Substances 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 claims 1
- 108010093096 Immobilized Enzymes Proteins 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 150000001538 azepines Chemical class 0.000 claims 1
- 230000007613 environmental effect Effects 0.000 abstract description 3
- -1 tert-butyl aztreonam Chemical compound 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- ISUIVWNWEDIHJD-UHFFFAOYSA-N 3-azaniumyl-2-methyl-4-oxoazetidine-1-sulfonate Chemical compound CC1C(N)C(=O)N1S(O)(=O)=O ISUIVWNWEDIHJD-UHFFFAOYSA-N 0.000 abstract 1
- 238000006555 catalytic reaction Methods 0.000 abstract 1
- 229960000484 ceftazidime Drugs 0.000 abstract 1
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 230000035484 reaction time Effects 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000969 carrier Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 3
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- RCZJVHXVCSKDKB-OYKKKHCWSA-N tert-butyl 2-[(z)-[1-(2-amino-1,3-thiazol-4-yl)-2-(1,3-benzothiazol-2-ylsulfanyl)-2-oxoethylidene]amino]oxy-2-methylpropanoate Chemical compound N=1C2=CC=CC=C2SC=1SC(=O)\C(=N/OC(C)(C)C(=O)OC(C)(C)C)C1=CSC(N)=N1 RCZJVHXVCSKDKB-OYKKKHCWSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- AXJDEHNQPMZKOS-UHFFFAOYSA-N acetylazanium;chloride Chemical class [Cl-].CC([NH3+])=O AXJDEHNQPMZKOS-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229940041009 monobactams Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- KZVLNAGYSAKYMG-UHFFFAOYSA-N pyridine-2-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=N1 KZVLNAGYSAKYMG-UHFFFAOYSA-N 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610718795.9A CN106520857B (zh) | 2016-08-25 | 2016-08-25 | 一种酶法合成氨曲南的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610718795.9A CN106520857B (zh) | 2016-08-25 | 2016-08-25 | 一种酶法合成氨曲南的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106520857A true CN106520857A (zh) | 2017-03-22 |
CN106520857B CN106520857B (zh) | 2020-01-07 |
Family
ID=58343600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610718795.9A Active CN106520857B (zh) | 2016-08-25 | 2016-08-25 | 一种酶法合成氨曲南的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106520857B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112645942A (zh) * | 2020-12-17 | 2021-04-13 | 山东罗欣药业集团恒欣药业有限公司 | 一种治疗细菌感染的化合物的新晶型及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007083187A2 (en) * | 2006-01-16 | 2007-07-26 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of monobactam antibiotic |
CN102127068A (zh) * | 2010-12-31 | 2011-07-20 | 山西普德药业股份有限公司 | 一种合成氨曲南化合物的方法 |
-
2016
- 2016-08-25 CN CN201610718795.9A patent/CN106520857B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007083187A2 (en) * | 2006-01-16 | 2007-07-26 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of monobactam antibiotic |
CN102127068A (zh) * | 2010-12-31 | 2011-07-20 | 山西普德药业股份有限公司 | 一种合成氨曲南化合物的方法 |
Non-Patent Citations (2)
Title |
---|
元英进: "《现代制药工艺学 上》", 31 July 2004 * |
龚大春: "《生物催化反应与转化原理》", 31 December 2006 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112645942A (zh) * | 2020-12-17 | 2021-04-13 | 山东罗欣药业集团恒欣药业有限公司 | 一种治疗细菌感染的化合物的新晶型及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106520857B (zh) | 2020-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103333942B (zh) | 左旋吡喹酮的合成方法 | |
JP5096435B2 (ja) | 光学活性α−メチルシステイン誘導体の製造方法 | |
CN103282350B (zh) | 制备雷米普利的方法 | |
US20090030210A1 (en) | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | |
CN106520857A (zh) | 一种酶法合成氨曲南的方法 | |
CN104830940A (zh) | 一种酶法合成阿莫西林的工艺 | |
CN101012181B (zh) | Dl-对氯苯丙氨酸的拆分方法 | |
KR20030087562A (ko) | 거울상이성체 강화된 β-아미노산의 효소에 의한 제조방법 | |
CN112195203B (zh) | 一种酶法合成(s)-2-氨基丁酰胺的方法 | |
JP5093248B2 (ja) | 光学活性インドリン−2−カルボン酸類またはその誘導体の製造方法 | |
CN102409068B (zh) | 一种(3aS,6aR)-生物素手性内酯的制备方法 | |
US6624311B2 (en) | Enantioselective enzymatic aminolysis of a racemic 2-isoxazolylacetate alkyl ester | |
CN110643625A (zh) | 一种重组表达质粒与基因工程菌及(4s,5r)-半酯的制备方法 | |
Ohishi et al. | Enantioselective synthesis of D-and L-α-methylcysteine with hydantoinase | |
CN105907832B (zh) | 一种酶法拆分艾沙康唑中间体的方法 | |
CN106636292B (zh) | (1r,4s)-(-)-2-氮杂双环[2.2.1]庚-5-烯-3-酮的制备方法 | |
CN109628504B (zh) | 一种利用微生物不对称拆分制备(s)-苯基乙二醇的方法 | |
WO2003042393A1 (en) | Enzymatic preparation of mycophenolate mofetil | |
JP5092466B2 (ja) | 光学活性ピペコリン酸またはその誘導体の製造方法。 | |
CN110358804B (zh) | R-3-氨基正丁醇的酶法生产工艺 | |
KR100345847B1 (ko) | 고정화효소에의한세파졸린의제조방법 | |
JP5092465B2 (ja) | ピペコリン酸の立体選択的なエステル化方法 | |
Sigmund et al. | Enantioselective enzymatic aminolysis of a racemic 2-isoxazolylacetate alkyl ester | |
EP1536017B1 (en) | Process for producing optically active octahydro-1H-indole-2-carboxylic acid | |
CN117947123A (zh) | 一种制备l-硫代脯氨酸的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method of enzymatic synthesis of aztreonam Effective date of registration: 20200730 Granted publication date: 20200107 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM Co.,Ltd. Registration number: Y2020980004549 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211115 Granted publication date: 20200107 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Registration number: Y2020980004549 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for enzymatic synthesis of aztreonam Effective date of registration: 20211201 Granted publication date: 20200107 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Registration number: Y2021980013624 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221115 Granted publication date: 20200107 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Registration number: Y2021980013624 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method of enzymatic synthesis of aztreonam Effective date of registration: 20221117 Granted publication date: 20200107 Pledgee: Jining City branch of the China Co truction Bank Corp. Pledgor: AMICOGEN (CHINA) BIOPHARM CO.,LTD. Registration number: Y2022980022253 |